Gayle Vranic is a Nephrology physician. OpenAlex indexes 13 publications with 317 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5 Hospital Dr
Charlottesville, VA 229080001
Telephone
434-924-5125Registry record last updated 27 Nov 2012.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Mallinckrodt Hospital Products Inc.Program year20231 payment
- Takeda Pharmaceuticals U.S.A., Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
43.9%Calcium channel blocker14.3%Amlodipine Besylate71%Nifedipine Er30%Part D<11 patientsBeta blocker10.3%Carvedilol84%Metoprolol Tartrate16%Part D<11 patients+ 4 more classes in this area
Metabolism & gastrointestinal
32.5%Corticosteroid13%Prednisone100%Part D≥40 patientsProton pump inhibitor8.4%Pantoprazole Sodium57%Omeprazole43%Part D≥19 patients+ 2 more classes in this area
Anti-infectives
8%Short-acting sulfonamides5%Sulfamethoxazole-Trimethoprim100%Part D≥17 patientsCytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor3%Valganciclovir Hcl100%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Induction of immune tolerance in living related human leukocyte antigen–matched kidney transplantation: A phase 3 randomized clinical trial
American Journal of Transplantation
2025 - <i>Bartonella quintana</i> Infection in Kidney Transplant Recipients from Donor Experiencing Homelessness, United States, 2022
Emerging infectious diseases
2024 - Evaluation of a multidisciplinary, multimodal pain management protocol following pancreas transplantation
Clinical Transplantation
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Giuseppe Remuzzi
Mario Negri Institute for Pharmacological Research
Marcello Tonelli
University of Calgary
Johan Ärnlöv
Dalarna University
Juan Jesús Carrero
Danderyds sjukhus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”